Fineotex Chemical Limited
Fineotex Chemical Limited Fundamental Analysis
Fineotex Chemical Limited (FCL.NS) shows moderate financial fundamentals with a PE ratio of 26.55, profit margin of 16.79%, and ROE of 13.18%. The company generates $0.7B in annual revenue with weak year-over-year growth of -6.26%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 49.6/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze FCL.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentFCL.NS demonstrates superior asset utilization.
Valuation Score
ModerateFCL.NS shows balanced valuation metrics.
Growth Score
WeakFCL.NS faces weak or negative growth trends.
Financial Health Score
ExcellentFCL.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateFCL.NS maintains healthy but balanced margins.
Key Financial Metrics
Is FCL.NS Expensive or Cheap?
P/E Ratio
FCL.NS trades at 26.55 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, FCL.NS's PEG of -0.46 indicates potential undervaluation.
Price to Book
The market values Fineotex Chemical Limited at 3.31 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 2.32 times EBITDA. This is generally considered low.
How Well Does FCL.NS Make Money?
Net Profit Margin
For every $100 in sales, Fineotex Chemical Limited keeps $16.79 as profit after all expenses.
Operating Margin
Core operations generate 17.52 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $13.18 in profit for every $100 of shareholder equity.
ROA
Fineotex Chemical Limited generates $11.07 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Fineotex Chemical Limited generates limited operating cash flow of $22.70M, signaling weaker underlying cash strength.
Free Cash Flow
Fineotex Chemical Limited generates weak or negative free cash flow of $9.17M, restricting financial flexibility.
FCF Per Share
Each share generates $0.08 in free cash annually.
FCF Yield
FCL.NS converts 2.79% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
26.55
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.46
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.31
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.50
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.01
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.13
vs 25 benchmark
ROA
Return on assets percentage
0.11
vs 25 benchmark
ROCE
Return on capital employed
0.13
vs 25 benchmark
How FCL.NS Stacks Against Its Sector Peers
| Metric | FCL.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 26.55 | 25.07 | Neutral |
| ROE | 13.18% | 989.00% | Weak |
| Net Margin | 16.79% | -108983.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.52 | Strong (Low Leverage) |
| Current Ratio | 4.01 | 6.35 | Strong Liquidity |
| ROA | 11.07% | -3359.00% (disorted) | Strong |
FCL.NS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Fineotex Chemical Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
168.37%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
711.17%
Industry Style: Cyclical, Commodity, Value
High GrowthFCF CAGR
139.67%
Industry Style: Cyclical, Commodity, Value
High Growth